BlackRock Fund Advisors has recently announced that it has increased stake in Exelixis Inc (NASDAQ:EXEL) by 1.79%. After grabbing 30.75 million shares, the institutional investor is now in possession of 0.54 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 9.89% having worth around $737.64 million. Moreover, Renaissance Technologies LLC increased its share by 0.57 million to have a control over 15.22 million shares. And Geode Capital Management LLC raised its holdings to 41242.0 shares by acquiring 5.07 million shares or 1.63% of the stake.
Exelixis Inc (EXEL) concluded trading on Thursday at a closing price of $22.09, with 3.02 million shares of worth about $66.66 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.45% during that period and on Thursday, January 25 the price saw a loss of about -0.09%. Currently the company’s common shares owned by public are about 323.95M shares, out of which, 301.17M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 79 times over the past 12 months. They bought 2,524,584 shares in 34 of the transactions. In 45 selling transactions, insiders dumped 1,410,492 shares.
Vanguard Total Stock Market ETF, iShares Core S&P Mid Cap ETF, and Vanguard Small Cap Index Fund are the top 3 mutual funds which are holding stakes in Exelixis Inc Vanguard Total Stock Market ETF is currently holding 9.77 million shares of worth totaling $234.29 million. The company recently came selling -0.22 million shares which brought its stake up to 3.14% of the company’s outstanding shares. iShares Core S&P Mid Cap ETF bought 8545.0 shares, after which its hold over company’s outstanding shares expand to 3.04%, leaving 9.45 million shares with the mutual fund that have a worth of about $226.67 million. Vanguard Small Cap Index Fund, after selling 7.92 million shares, have now control over 2.55% of the stake in the company. It holds -0.33 million shares of worth $189.99 million.
However, the stock later moved at a day high price of 22.45, or with a loss of -0.09%. Stock saw a price change of -0.81% in past 5 days and over the past one month there was a price change of -7.73%. Year-to-date (YTD), EXEL shares are showing a performance of -7.92% which increased to 27.25% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $16.15 but also hit the highest price of $24.34 during that period. The average intraday trading volume for Exelixis Inc shares is 2.20 million. The stock is currently trading -4.31% below its 20-day simple moving average (SMA20), while that difference is down -1.78% for SMA50 and it goes to 5.98% higher than SMA200.
BlackRock Fund Advisors acquired 30.75 million shares of Exelixis Inc having value of about $737.64 million. Data submitted at the U.S SEC by BlackRock Fund Advisors revealed that the firm now holds 0.54 million shares in the company valued at close to $11915213.46, or have control over 1.79% stake in the company. Exelixis Inc (NASDAQ: EXEL) currently have 323.95M outstanding shares and institutions hold larger chunk of about 85.82% of that. Holding of mutual funds in the company is about 42.21% while other institutional holders and individual stake holders have control over 43.62% and 4.69% of the stake respectively.
The stock has a current market capitalization of $6.87B and its 3Y-monthly beta is at 0.53. PE ratio of stock for trailing 12 months is 78.72, while it has posted earnings per share of $0.28 in the same period. Its PEG reads 4.14 and has Quick Ratio of 3.76 while making debt-to-equity ratio of 0.08. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EXEL, volatility over the week remained 2.28% while standing at 2.71% over the month.
Analysts are in expectations that Exelixis Inc (EXEL) stock would likely to be making an EPS of $Exelixis, Inc. in the current quarter, while forecast for next quarter EPS is $22.09 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Xcel Energy Inc. which is $Exela Technologies, Inc. at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Exela Technologies, Inc. – 6.00 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 15.48% while it is estimated to increase by 75.30% in next year. EPS is likely to grow at an annualized rate of 19.00% for next 5-years, compared to annual growth of 2.77% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by BTIG Research on December 19, 2023 offering a Buy rating for the stock and assigned a target price of $27 to it.
